Agentic AI in AWM – Navigating the Future of Wealth Management
AWM Insights Series Episode 2: Agentic AI in AWM – Navigating the Future of Wealth Management Watch Episode Overview Navigating the
AWM Insights Series Episode 2: Agentic AI in AWM – Navigating the Future of Wealth Management Watch Episode Overview Navigating the
AWM Insights Series Episode 1: Key Insights on Global Asset & Wealth Management (AWM) for 2025 Watch Episode Overview Shaping the
Explore the 2025 global economic outlook and strategies for growth in the shadow of geopolitics, addressing trade wars, tariffs, and commodity market dynamics.
Stay ahead in the lending industry by exploring the latest trends, industry themes, and market updates in this newsletter.
Discover the growing e-commerce market in Europe between 2023-2027. Gain insights on consumer habits, trends, and forecasts to stay competitive.
Discover the latest trends in transport, travel, logistics & infrastructure. Gain valuable insights into the industry with our comprehensive analysis for 2024.
Explore how financial institutions are transforming Model Risk Management with new tools, automation, and AI in this collaborative report by Chartis Research and Evalueserve.
Discover how the circular economy can reduce CO2 emissions, cut costs, and create jobs while extending resource life cycles.
Discover the snacking industry’s evolution from indulgent treats to essential diet components, driven by consumer trends and regulations.
Explore the stages of financed emissions reporting maturity and the challenges faced by banks. Gain insights on overcoming data issues and improving accuracy in our in-depth report.
Discover how international collaboration is driving the sustainable development of China’s renewable energy sector and shaping the future of green finance.
Celebrate Earth Day 2024 by integrating sustainability as a fundamental value in your business and implementing comprehensive strategies for environmental protection and prosperity.
Explore the impact of inflation, interest rates, and central bank actions on the stock market over 25 years, and learn how these factors can influence your investments.
Explore the new draft guidelines for mandatory sustainability reporting in Mainland China, aiming to standardize ESG disclosures and align with international frameworks.
Explore FDA’s requirements on CAR-T Therapy, as it mandates black box warnings for six approved therapies, prioritizing patient safety in the evolving market landscape.
Explore the transformative power of ESG disclosure in driving corporate accountability, fostering informed investment decisions, and improving access to capital.
Explore China’s Sustainability Newsletter for Q4 2023, featuring updates on carbon trading, hydrogen energy guidelines, green bonds, and more, as the country advances towards carbon neutrality.
A glimpse of orthopedic industry and recent updates. Top orthopedic players boosting the ortho market with new innovations and technologies. Key highlights showcasing the advancement and trends in the market.
The whitepaper provides a forecast for digital transactions and outlines the critical role played by anti-fraud services in securing transactions.
Explore the impact of China’s Q3 2023 GDP growth on research operations, investment opportunities, and the potential for increased demand in the Chinese stock market.
Explore UBS’s strategic move to free up capital by inviting bids for CS’s China brokerage unit, addressing license restrictions and potential impact on growth.
Saudi Arabia’s digital transformation (DX) initiatives are focused on promoting Industry 4.0, smart city, and smart metering solutions. DX is enabling the expansion of IT services, enhancing digital infrastructure, and fueling the exploration of emerging technologies, all of which are driving the demand for IoT in the kingdom.
This report offers valuable insights into the evolving landscape of ESG (Environmental, Social, and Governance) data, drawing on Evalueserve’s over two decades of specialized expertise in this domain.
Explore China’s Sustainability Newsletter for Q3 2023, featuring updates on carbon trading, hydrogen energy guidelines, green bonds, and more, as the country advances towards carbon neutrality.
The United Nation’s Sustainable Development Goals (SDGs) face a critical juncture. At the halfway point to 2030, the world is not on track to achieve the SDGs agreed to in 2015.
Comparing Environmental, Social, and Governance (ESG) data across companies can be challenging due to issues with data quality and completeness, as well as the lack of standardization. This report highlights the difficulties users face when attempting to use ESG data to make meaningful comparisons.
This report assesses the Transportation, Tourism, Logistics & Infrastructure (TTL/I) industry in H1 2023, covering the current and future state, as well as industry trends.
Our report focuses on the impact of Artificial Intelligence and AI-powered tools on the collection and analysis of ESG data. Evalueserve is leading the way in this transformation by utilizing our 20 years of ESG experience to design and develop tools that use AI to improve accuracy, efficiency, and transparency.
Discover the Corporate Sustainability Reporting Directive (CSRD) and its impact on large companies, including Scope 3 emission reporting requirements and adherence to European Sustainability Reporting Standards (ESRS).
Seize opportunities in escalating chip geopolitics. Semiconductor equipment manufacturers prepare for market expansion amid global demand and investment boom.
The latest Tracking-the-trends document highlights the recent product launches in the asset management industry, focusing on the new funds introduced in 2023 by leading US asset managers.
Despite political polarization and state-level restrictions, global ESG regulations are on the rise, and the pending EU Corporate Sustainability and Reporting Directive will impact thousands of companies worldwide, indicating the continued importance and growth of ESG reporting. Read about this and more in our Q2 2023 ESG Newsletter.
Discover the latest insights in our sustainability newsletter, covering China’s sustainability trends, green finance news, carbon trading, and policy updates.
In today’s post-pandemic era, industries across the board are witnessing remarkable transformations, and the pharmaceutical industry is no exception. This critical pillar of the healthcare sector is undergoing a profound transformation fueled by the power of digitalization.
Explore the rapidly evolving world of clear aligners and their integration into digital dental workflows. Learn about top dental companies, workflow compatibility, and the benefits of seamless integration for dentists and patients.
Explore the US Securities and Exchange Commission’s proposed rule for climate-related disclosures, including Scope 3 emissions reporting, reactions from industries, and potential scenarios. Stay ahead in the journey to net-zero emissions.
Discover the highlights of ASGCT Annual Meeting 2023, featuring breakthroughs in biotechnology, novel approaches, and innovative technologies in the CGT space. Stay updated on the latest advancements and industry trends.
POV on Clear Aligners: Current & Future Trends Get My Publication Overview Traditionally, orthodontists used to treat malocclusion cases among kids,
Discover the transformative potential of GenAI in FinTech, driving innovation, improving customer experience, and reducing costs while addressing key risks and challenges.
Explore Evalueserve’s innovative C.A.S.E. methodology for comprehensive ESG controversy assessments, empowering investors to make informed decisions and build resilient, sustainable portfolios.
To effectively shape a company’s ESG strategy and communicate its performance, it is crucial to have a benchmarking process in place, but relying on scores alone is risky; enhanced insights drive effective decisions.
SMB (Small and Mid-sized Businesses) market holds huge opportunity, but at the same time, post pandemic economic uncertainties are forcing SMBs to make cautious IT spend decisions. Despite limited new IT investments, challenges with incumbent vendors is creating a massive market potential. Enterprises need to understand the changing needs and preferences of SMBs, and tailor made their targeting strategies.
Discover the key factors in choosing a hearing aid, from severity of hearing loss to warranty and trial periods. Explore the latest technological advancements and growing demand for OTC products.
With the consistent success of cell and gene therapies (CGTs), bioprocessing and the manufacturing facilities have taken centre-stage to meet global demands.
PE firms are investing billions in ProSports franchises given the scarcity and strong returns delivered by the asset class. Despite many challenges, stakeholders are willing to work with PE funds for growth prospect.
Digital technology, such as AI, big data analytics, wearables, and robotics, has revolutionized healthcare in the past decade with surgical robotics, improving accessibility, efficiency, and equity.
Discover why WhatsApp Pay is trailing behind its peers according to a Quick Byte Research study. Security concerns and limited interest due to current payment options are among the factors hindering its adoption.
In this quarter, China has taken various actions to promote the renewable energy transition. Domestically, China government launched a national Climate Prediction Model for wind and solar resources. Internationally, China Energy has proposed the construction of a 1,000-megawatt floating solar plant in Zimbabwe and LONGi Green Energy plans to build a $600 Million Solar Panel Plant in the U.S.
Role of Knowledge Management for Professional Services Firms Speak to Our Experts Why is Knowledge Management (KM) important for modern firms?
In the rapidly evolving field of ophthalmic surgery, staying at the forefront of technological advancements and understanding the competitive landscape is crucial for success. With increasing demands for better patient outcomes and cost-effective solutions, market players are constantly striving to innovate and outperform their competitors. Our medtech team has expertly curated a comprehensive analysis, delving into the strategic perspectives of key competitors, emerging trends, and future outlook across four essential pillars shaping the ophthalmology landscape.
Evalueserve’s investment banking experts put together an in-depth review of how the industry fared in FY 2022 and where it’s expected to go in FY 2023. This report includes a round-up of the activities and performances of many major investment banks and M&A advisory firms.
Each year, the incidence of transplants is increasing. Consequently, population of patients with Graft-versus-Host Disease (GvHD) is on the rise. This is especially true for chronic GvHD for which the incidence has been recorded as high as 80%. The frontline treatment is dominated by corticosteroids and other immunosuppressants. However, the refractory nature of the disease requires patients to move on to later lines of treatment, which currently are limited.
Almost 80-85% of the post-menopausal women population in the world suffer from vasomotor symptoms (VMS) such as hot flashes, night sweats and other associated symptoms. However, due to the stigma and misinformation associated with women’s health and especially menopause, it still remains an area that is understudied in research, often misunderstood by healthcare providers and patients, and unaddressed by most healthcare policies.
As a central driving force for precision medicine worldwide, the Personalized Medicine Coalition (PMC) noted that more than 220 FDA-approved therapies with a biomarker mentioned in the label as ‘essential’ or ‘recommended for prescribing’ were available in the US market between 2015 and 2021. Further fuelling the movement of value-based care, a drug-diagnostic co-development model has been significantly prevalent, leading to a consistently growing usage of companion diagnostics assays – to target patients expected to benefit most from targeted therapy. As of 2022, 40+ commercialized CDx assays were listed exhaustively in the FDA’s List of Cleared or Approved Companion Diagnostic Devices.
Acute Myeloid Leukemia (AML) is a uniquely challenging disease in which 50-80% patients eventually relapse following induction and/or post-remission therapies and with 5-year survival rate of merely 30%. Drug development in AML has been challenging in the past, with multiple failures and modest commercial success.
The Evalueserve medtech team summarizes highlights from key medical devices and diagnostic players presented and discussed at JP Morgan Healthcare Conference 2023.
2022 marked a tumultuous year for ESG and sustainability. The recent COP27 talks required overtime to produce a final document to avoid derailing years of progress on climate change. Moreover, geopolitical events and their economic impact upset the momentum fueling the prolific ESG investing of late. Nevertheless, despite headwinds, ESG-related investments remain substantial.
In the last quarter of 2022, Hong Kong jurisdiction unveils vigorous initiatives toward sustainable development. Meanwhile, China’s national ETS achieved a 10-billion-yuan (US$1.4 billion) transaction value in December.
Evalueserve brings to you a brief snapshot of epilepsy showcasing current market, future trends and potential recommendations in the space, read our brief take on Epilepsy Perspective and Trends.
ASH 2022 (Dec 10-13) is approaching and destined to re-energize and re-catalyse the global hematology community. Here are some picks of key players and interesting abstracts in CAR-T and T-Cell Engager space.
As connected and autonomous vehicles gain traction, vehicles in the future will likely be equipped with highly customized display panels that provide a connected, safe, personalized, intelligent, productive, and entertaining end-to-end experience. In-vehicle display technologies such as Holography, Augmented reality, and Curved/flexible displays are gaining prominence.
Whether driven by investors’ concerns, regulatory mandates, or broader social norms, the number of corporations pledging net zero GHG emissions goals continues to increase. More than 750 of the world’s 2,000 largest publicly traded corporations have announced net zero goals.
In this quarter, China’s carbon emission trading market has turned one year old. The country’s cumulative trading volume of carbon emission quota had reached 194 million tons, with a total trading value of 8.49 billion yuan. Also, following the national Dual Carbon goal, provinces and cities in China have successively published their own Implementation Plan for Carbon Peaking.
ESMO 2022 (09-13 September) has concluded. Evalueserve presents succinct reflection of key abstracts that managed to create significant stir across five broad themes of ADCs, Precision Oncology, Early Assets, Practice informing readouts and Out of the box findings. The report uncovers clinical data spotlight accompanied with latest industry perceptions and Twitter intelligence.
The global EV charging market is expected to reach USD 30.4 billion by 2023 and USD 35 billion by 2026. Extensive research in EV charging tech is vital for sustainable growth.
Global consumption of refined zinc increased by 6.3% year on year in 2021 to reach just over 14 million tones. This expansion included robust growth in the three largest consumer markets of China, Rest of Asia and the EU.
While the Indian EV market is growing at a brisk pace and so are plans and investments related to the development of charging infrastructure, the utilization rate of public charging stations in the country stands at a mere 7%…
SPACs took the world by storm in 2021, however it also attracted the attention of regulators along with investors. 2022 proved to be the year of deceleration for SPAC industry but possibly it will speed up again in 2023. Read more in our latest overview on SPAC
Digital healthcare gained great prominence following the outbreak of COVID-19, as patients wanted to feel more empowered than ever before. Many venture funds stepped up to fund advanced digital health technology companies that were focused on AI-based data-driven connected technologies.
In this quarter, China is strengthening its disclosure by taking into effect the new ESG Disclosure Standard on 1 June. Also, a series of policies was published to promote energy efficiency and renewable energy transition for achieving the national Dual Carbon targets.
Despite sky-high fuel prices providing historic profits for suppliers – the IEA expects net revenue for the world’s oil and gas producers to double to an unprecedented $4tn – “investment in oil, gas, coal, and low-carbon fuel supply is the only area that, in aggregate, remains below the levels seen prior to the pandemic in 2019.
There are signs hinting at an impending bullwhip effect on supply chains, which could mean that supply chain managers need to recalibrate their decisions with respect to the new emerging market realities. As governments eased COVID-related restrictions, economies across the globe witnessed a demand surge. Businesses ramped up production to meet growing demand.
The post-conference report curated by Evalueserve mirrors the most impactful findings from lung cancer, breast cancer and acute myeloid leukemia in 2022.
Check out the hottest news in ESG with the Q2 2022 edition of our ESG Newsletter.
The first quarter of the year has been characterized by geo-political tension, inflationary concerns, and extreme market volatility. These have had a detrimental impact on the investment banking revenues of all the bulge bracket banks. The only light at the end of the tunnel seemed to be the ‘normalisation’ of interest rates and a heightened trading activity which served as a surprise bailout factor.
An agile approach to business strategy is not just about velocity to adapt to evolving market needs but also, how efficiently to out-innovate the competition. Business leaders are constantly facing new market challenges, many of which are known while others unknown. It is becoming increasing important to continuously observe the market signals and respond timely for mitigating the risks and ensuring business growth sustainability.
The ICER has backed bluebird bio’s revolutionary Zynteglo therapy for beta thalassaemia as cost-effective in their draft report. Will FDA’s additional back-to-back endorsement of Zynteglo and eli-cel pave the way for bluebird’s recovery, despite multiple misfires and dwindling finances?
M&A activity is down in Q1’22. Shift towards energy transition, building ESG strategies, and portfolio optimization will drive M&A activities in 2022.
Supply chain management is undergoing a paradigm shift. In the current market, supply chain managers are faced with a few key challenges – ensuring business / production continuity, building safeguards against future supply chain disruptions, and contributing to their organizations’ sustainability journeys.
After experiencing record growth and a strong M&A environment in 2021, the North American consumer and retail sector was hit by a series of macroeconomic headwinds in Q1 2022, including inflation and interest rates, supply chain disruptions, and the Russia-Ukraine conflict. Amid tightening labor market and rising incomes, inflation is increasing the pricing of consumer staples, leaving less money available for discretionary purchases.
In Q1 2022, the global economy was affected by several factors such as inflation, high interest rates, and the Russia-Ukraine conflict. These factors also affected the technology sector as it experienced lower listing activity, and weaker stock performances and valuations. However, the sector’s long-term outlook is positive and it is expected to experience normalized growth for the remainder of 2022. This update covers the technology sector’s Q1 2022 performance and 2022 outlook.
The Cannabis Industry has been emerging as a multi-billion dollar industry with legalization continuing to evolve amid growing public support and favorable bills and acts. North America, one of the major contributors of the Global Cannabis Market generated a net sales of $22.9 billion in 2020 and is expected to grow in line with the Global CAGR of ~17% for the next 5 years and reach ~$50 billion by 2025.
The ongoing geo-political tensions, inflationary pressures, and extreme market volatility has halted investment banking revenues of the bulge bracket banks in the first quarter of 2022. However, advisory revenues remained robust as firms ramped up their internal pipelines and hired senior executives.
Shockwaves from the Ukraine Crisis and tightening of financial conditions have tested the Financial System’s resilience in 1Q’22. Deal activity across all the sub-sectors declined as investors traded cautiously while deploying their capital.
In a world of traditional banking when a customer applied for a loan, it took weeks to get to the loan approval decision. Traditional banks made the process seem as difficult as swimming across an ocean!
Fueled by rising geopolitical tensions in the wake of the Russia-Ukraine conflict, worsening macro-economic outlook, higher interest rates, and supply chain disruptions have all led to dampening investments activity, particularly in M&A hubs in Asia-Pacific including China, Japan, and South Korea.
EdTech has been around for two decades, but it gained prominence worldwide during the COVID-19 pandemic. Educational institutions were forced to adopt digital solutions to ensure learning continuity.
The start of 2022 has been in stark contrast to the economic buoyancy witnessed last year. Even though it has been almost two years since the outbreak of COVID-19, the pandemic is still proving to a challenge for governments across the globe.
More than one year has now passed since China’s initial announcement of achieving Carbon Neutrality by 2060, also known as “30-60” Goals. Following the announcement, various measures have been introduced across the country starting from the province/city level to the institution and company level to align with the national target.
In this industry expert we discuss what DI is, it’s advantages, challenges and how it can provide a competitive advantage for investors.
As we transition through the first quarter of 2022, the team at Evalueserve brings you another iteration of our M&A Recovery Report for eight major M&A markets. Click here to read deeper insights on M&A Trends and Outlook in Q1 2022.
Our detailed review of the Q1 2022 results of the US bulge bracket investment banks captures the key factors impacting growth and the potential path forward.
Largest independent provider of research and analytics support, with a strong focus on innovation.
Check out the hottest news in ESG with the Q1 2022 edition of our ESG Newsletter.
Our detailed analysis of the 2021 Global Investment Banking review captures the trends in the M&A, ECM & DCM markets, and full year performance of bulge bracket investment banks & M&A advisory firms.
Our detailed analysis of the M&A and Capital Markets landscape captures deep insights into the investors’ behavior, consolidator’s dry powder, M&A appetite across sub-sectors, availability cash runaways, SPACs’ sustainability and key sectoral outlook, among others.
In 2020, the COVID-19 pandemic catapulted various organizations into the future, as businesses rapidly accelerated their digital transformation efforts.
It has been almost two years since the outbreak of COVID-19, but the pandemic still rages on. Vaccine rollout and policy support have continued to witness divergence across regions. The consistent and equitable implementation of tools to control the pandemic continues to be a challenge for governments across the globe.
In this Oil & Gas Industry update, we discuss oil price rise due to opening of economies coupled with how vaccination programs roll out have fueled much needed impetus to the M&A drive in the sector.
Over the last couple of years, the COVID-19 pandemic has reshaped markets and sectors, especially in terms of consumer behavior.
Check out the hottest news in ESG with the Q4 2021 edition of our ESG Newsletter.
As we approach the end of 2021 it seems that the Financial Services Industry’s pandemic driven headwinds have finally bottomed out.. The resurgence of ‘big ticket’ deals during the year has proved to be a light at the end of the tunnel after a difficult 2020.
In 2020, the technology sector pushed the Wall Street to get rid of the pandemic-led bear market and form a new bull market.
M&A market sentiment in APAC seems cautiously optimistic and positive. Momentum in deal making activity has continued and led to a Y-o-Y growth of 78% and high growth in technology, energy and consumer space, seemed to be the common theme across capital markets.
As the fight against COVID-19 continues, economic recovery across economies has been diverging due to differences in the pace of vaccine rollout and policy support. Mass vaccination drives by advanced economies are driving positive market sentiments.
Electric vehicles (EVs) are the future of the automotive sector, and not a distant one. EVs, in their various forms, from plug-in hybrids (PHEVs) to battery electrics (BEVs) as well as the upcoming hydrogen fuel cell EVs (FCEVs), are racing towards ubiquity carried along by the fervor for the net-zero carbon emissions by 2050 mission.
Energy transition is the core component of the global target to achieve net-zero carbon emissions by 2050 across geographies and industries. Although, as we dive deeper into the scale and pace of the efforts needed to limit global temperatures from rising by 1.5 degrees C, the word “energy transition” loses some of its relevance.
The oil field services (OFS) business suffered a double whammy in 2020 – depleting oil prices as well as COVID-19 – both of which led to deep cuts in capital expenditure by their customers and a negative impact on their profit margins.
Decarbonization is no longer simply a buzzword. It is here and the voices echoing it will only multiply and get louder as the global economies inch towards 2050. By this year, most developed nations have pledged to become carbon emissions neutral economy wide.
The London Inter-bank Offer Rate (LIBOR) is the most important rate globally, referencing nearly USD 370 trillion (as of 2018) equivalent of contracts that cover a myriad of products such as mortgages, bonds, and derivatives.
The objective of the stress testing is to understand the resilience of UK-based Banks and Insurance agencies from physical and transition risks emanating from climate change.
While data can certainly be used to keep financial organizations informed and reduce their exposure to risk, it is important to consider what sort of data is most useful and what is the most effective way of gathering and using it. Not all data or all data management systems are equal.
On April 22, 2021, United States President Joe Biden made a remarkable, if ambitious, announcement. Contrary to the previous Trump administration’s climate change denial, Biden has said that the government will cut America’s greenhouse gas (GHG) emissions 50 to 52 percent from their 2005 levels within this decade.
The use of hydrogen in industrial applications such as oil refining and ammonia production is not new, but it is yet to be adopted at scale in other industries such as transport and power generation.
LatAm M&A activity slowed in 2020 due to volatility caused by COVID-19. Deal volumes declined through most of Latin America in 2020.
The traditional types of risk such as credit and market risk are about losses and are able to be quantified. It may not always be easy to mitigate risk, but the first step is to gather data and make calculations that provide a basis for decisions about whether any given business is worth doing.
Taking a strategic review of VaR models uncovers shortcomings in market risk modelling approaches, stress testing, FO integration, and Market Risk systems and processes.
The spike in SPAC activity has two main causes: the increase in volatility in the markets due to the COVID-19 pandemic, making SPACs more appealing than traditional IPOs; and the large number of billionaire investors and bulge bracket banks sponsoring SPACs, which caught the attention of the public
The COVID-19 pandemic and related lockdowns brought the global M&A market to a halt in H1 2020. Both domestic and cross-border deals declined, amid the pandemic-induced uncertainties.
The International Accounting Standards Board (IASB) published the draft proposal of a new standard, General Presentation and Disclosures in December 2019, which is expected to replace the existing IAS 1.